Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neulasta PROs in Advanced NSCLC
NCT00115206Phase 4Completed
- Sponsor
- Amgen
- Start
- Jul 2002
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 4 trial of pegfilgrastim in neutropenia, sponsored by Amgen. Started Jul 2002; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NCT00115206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00115206.